SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:su-210357"
 

Search: onr:"swepub:oai:DiVA.org:su-210357" > Advanced Molecular ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004030naa a2200721 4500
001oai:DiVA.org:su-210357
003SwePub
008221012s2022 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-2103572 URI
024a https://doi.org/10.1021/jacsau.2c002202 DOI
040 a (SwePub)su
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Weil, Tatjana4 aut
2451 0a Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory Viruses
264 c 2022-09-06
264 1b American Chemical Society (ACS),c 2022
338 a print2 rdacarrier
520 a The COVID-19 pandemic caused by SARS-CoV-2 presents a global health emergency. Therapeutic options against SARS-CoV-2 are still very limited but urgently required. Molecular tweezers are supramolecular agents that destabilize the envelope of viruses resulting in a loss of viral infectivity. Here, we show that first-generation tweezers, CLR01 and CLR05, disrupt the SARS-CoV-2 envelope and abrogate viral infectivity. To increase the antiviral activity, a series of 34 advanced molecular tweezers were synthesized by insertion of aliphatic or aromatic ester groups on the phosphate moieties of the parent molecule CLR01. A structure-activity relationship study enabled the identification of tweezers with a markedly enhanced ability to destroy lipid bilayers and to suppress SARS-CoV-2 infection. Selected tweezer derivatives retain activity in airway mucus and inactivate the SARS-CoV-2 wildtype and variants of concern as well as respiratory syncytial, influenza, and measles viruses. Moreover, inhibitory activity of advanced tweezers against respiratory syncytial virus and SARS-CoV-2 was confirmed in mice. Thus, potentiated tweezers are broad-spectrum antiviral agents with great prospects for clinical development to combat highly pathogenic viruses.
650 7a NATURVETENSKAPx Kemi0 (SwePub)1042 hsv//swe
650 7a NATURAL SCIENCESx Chemical Sciences0 (SwePub)1042 hsv//eng
653 a broad-spectrum antivirals
653 a SARS-CoV-2
653 a RSV
653 a molecular tweezers
653 a respiratory viruses
700a Kirupakaran, Abbna4 aut
700a Le, My-Hue4 aut
700a Rebmann, Philipp4 aut
700a Mieres-Perez, Joel4 aut
700a Issmail, Leila4 aut
700a Conzelmann, Carina4 aut
700a Müller, Janis A.4 aut
700a Rauch, Lena4 aut
700a Gilg, Andrea4 aut
700a Wettstein, Lukas4 aut
700a Groß, Rüdiger4 aut
700a Read, Clarissa4 aut
700a Bergner, Tim4 aut
700a Axberg Pålsson, Sandra,d 1991-u Stockholms universitet,Institutionen för molekylär biovetenskap, Wenner-Grens institut4 aut0 (Swepub:su)sapa8421
700a Uhlig, Nadja4 aut
700a Eberlein, Valentina4 aut
700a Wöll, Heike4 aut
700a Klärner, Frank-Gerrit4 aut
700a Stenger, Steffen4 aut
700a Kümmerer, Beate M.4 aut
700a Streeck, Hendrik4 aut
700a Fois, Giorgio4 aut
700a Frick, Manfred4 aut
700a Braubach, Peter4 aut
700a Spetz, Anna-Lena,d 1947-u Stockholms universitet,Institutionen för molekylär biovetenskap, Wenner-Grens institut4 aut0 (Swepub:su)aspet
700a Grunwald, Thomas4 aut
700a Shorter, James4 aut
700a Sanchez-Garcia, Elsa4 aut
700a Schrader, Thomas4 aut
700a Münch, Jan4 aut
710a Stockholms universitetb Institutionen för molekylär biovetenskap, Wenner-Grens institut4 org
773t JACS Aud : American Chemical Society (ACS)g 2:9, s. 2187-2202q 2:9<2187-2202x 2691-3704
856u https://doi.org/10.1021/jacsau.2c00220y Fulltext
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-210357
8564 8u https://doi.org/10.1021/jacsau.2c00220

Find in a library

  • JACS Au (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view